Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
- Genomic alignments
- Gene tree
- Gene gain/loss tree
- Orthologues
- Paralogues
- Strains
  - Gene tree
  - Orthologues
  - Paralogues
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: 4933435F18Rik ENSMUSG00000086978

.

Description

RIKEN cDNA 4933435F18 gene [Source:MGI Symbol;Acc:MGI:1918570]

Location

Chromosome 4: 124,196,625-124,226,378 reverse strand.

GRCm39:CM000997.3

About this gene

This gene has 16 transcripts (splice variants) and 3 orthologues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	CCDS	Flags
ENSMUST00000153719.3	4933435F18Rik-202	1333	No protein	-	lncRNA		A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, GENCODE Primary represents a minimal set that contains MANE Select, MANE Plus Clinical and Ensembl Canonical transcripts and transcripts containing any conserved exons and common alternative splicing events (including exons skips) that are absent from the MANE and Ensembl Canonical transcripts for protein-coding genes. Other biotypes will have the GENCODE Primary flag added to the Ensembl Canonical transcript and for lncRNA genes only this will be the transcripts with the longest genomic span.GENCODE Primary, TSL 1: A transcript where all splice junctions are supported by at least one non-suspect mRNA. The Transcript Support Level (TSL) is a method to highlight the well-supported and poorly-supported transcript models for users, based on the type and quality of the alignments used to annotate the transcript. TSL:1,
ENSMUST00000154878.2	4933435F18Rik-203	2174	No protein	-	lncRNA		A subset of the GENCODE transcript set, containing only 5' and 3' complete transcripts at protein-coding genes.GENCODE Basic, TSL 1: A transcript where all splice junctions are supported by at least one non-suspect mRNA. The Transcript Support Level (TSL) is a method to highlight the well-supported and poorly-supported transcript models for users, based on the type and quality of the alignments used to annotate the transcript. TSL:1,
ENSMUST00000365762.1	4933435F18Rik-206	1673	No protein	-	lncRNA		-
ENSMUST00000365764.1	4933435F18Rik-208	1542	No protein	-	lncRNA		A subset of the GENCODE transcript set, containing only 5' and 3' complete transcripts at protein-coding genes.GENCODE Basic,
ENSMUST00000365771.1	4933435F18Rik-215	1409	No protein	-	lncRNA		-
ENSMUST00000365769.1	4933435F18Rik-213	1406	No protein	-	lncRNA		A subset of the GENCODE transcript set, containing only 5' and 3' complete transcripts at protein-coding genes.GENCODE Basic,
ENSMUST00000365761.1	4933435F18Rik-205	1380	No protein	-	lncRNA		-
ENSMUST00000365768.1	4933435F18Rik-212	1363	No protein	-	lncRNA		-
ENSMUST00000365763.1	4933435F18Rik-207	1357	No protein	-	lncRNA		-
ENSMUST00000365760.1	4933435F18Rik-204	1258	No protein	-	lncRNA		-
ENSMUST00000365770.1	4933435F18Rik-214	1158	No protein	-	lncRNA		-
ENSMUST00000365766.1	4933435F18Rik-210	1118	No protein	-	lncRNA		-
ENSMUST00000365772.1	4933435F18Rik-216	1061	No protein	-	lncRNA		-
ENSMUST00000365765.1	4933435F18Rik-209	1037	No protein	-	lncRNA		-
ENSMUST00000125578.3	4933435F18Rik-201	815	No protein	-	lncRNA		TSL 1: A transcript where all splice junctions are supported by at least one non-suspect mRNA. The Transcript Support Level (TSL) is a method to highlight the well-supported and poorly-supported transcript models for users, based on the type and quality of the alignments used to annotate the transcript. TSL:1,
ENSMUST00000365767.1	4933435F18Rik-211	811	No protein	-	lncRNA		-

.

Summary

.

.